Stem Cell Reagents
Cells
3D Cell Culture
Labware
Human Tissue Samples
NEW Oligonucleotide Synthesis
REPROCELL Brands
All brands in the REPROCELL product catalog
Leveraging Human Tissue Models with Preclinical and Drug Discovery CRO
05 April 2024
ec23: A Promising ATRA Alternative for Advancing Stem Cell Research
13 December 2023
Quality Control: What is really in your hiPSC culture?
11 December 2023
Exploring CHIR99021: The Key to Stem Cell Research and Beyond
20 November 2023
New from REPROCELL: GMP Grade Stem Cell Master Cell Bank Service Expansion
18 April 2024
[PRESS RELEASE:] REPROCELL’s New Clinical Pipeline: Tumor Infiltrating Lymphocyte Infusion Therapy (TIL Therapy)
08 February 2024
Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu
31 January 2024
Blog posts tagged:
The REPROCELL Blog
The influence of the microbiome on inflammatory bowel disease
18 March 2022
4 reasons human tissues should be used to predict drug bioavailability
29 January 2020
IBDiscovery: Combining patient and drug discovery data to transform healthcare
16 September 2019
An Improved Model for IBD Drug Discovery
11 July 2019
Advances in diagnostics, treatments, and frontiers of research in IBD
13 June 2019
Subjects we write about
Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.
More about REPROCELL